Gravotta E

No ORCID on file · 1 paper in corpus · active 2025
2025
Effectiveness and safety of follitropin delta in routine clinical practice in the Nordics and Switzerland (the NORSOS study): a prospective non-interventional study.
Frontiers in endocrinology ·doi:10.3389/fendo.2025.1613680

BackgroundFollitropin delta is the first approved human recombinant follicle-stimulating hormone treatment administered through an algorithmic individualized dosing regimen based on body weight and anti-Müllerian hormone (AMH) levels. This …